Percutaneous Vascular Stent Implantation as Treatment for Central Vascular Obstruction Due to Fibrosing Mediastinitis | Zendy

Erin L. Albers | Zendy; Meredith E. Pugh | Zendy; Kevin D. Hill | Zendy; Li Wang | Zendy; James E. Loyd | Zendy; Thomas P. Doyle | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Percutaneous Vascular Stent Implantation as Treatment for Central Vascular Obstruction Due to Fibrosing Mediastinitis

Author(s) -

Erin L. Albers,

Meredith E. Pugh,

Kevin D. Hill,

Li Wang,

James E. Loyd,

Thomas P. Doyle

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.110.949180

Subject(s) - medicine , surgery , mediastinitis , percutaneous , stent , stenosis , cardiac catheterization , superior vena cava syndrome , percutaneous coronary intervention , complication , pulmonary artery , radiology , superior vena cava , cardiology , myocardial infarction

Fibrosing Mediastinitis (FM) is a rare complication of infection with Histoplasma capsulatum that can lead to obstruction of pulmonary and systemic vasculature and large airways, often resulting in significant morbidity and mortality. Medical therapy is ineffective, and surgical intervention is often not feasible. Stent implantation offers a potential treatment for vascular obstruction due to FM, but this has not been well studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research